Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02910986 · ClinicalTrials.gov registry record · NA
Behavioral and Psychological Impact of Returning Breast Density Results to Latinas
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,386
- Enrollment target
NCT02910986: Completed NA study, sponsored by Mayo Clinic.
NCT02910986 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 1,386 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02910986, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,386 participants
- Enrollment target
Study Summary
This study will examine behavioral and psychological outcomes of breast density notification using a 3-group randomized design comparing usual written notification to two educationally enhanced approaches.
Primary Outcome
Percentage of women who provided an incorrect response as to whether dense breasts impact the ability of a mammogram to correctly detect cancer at T0 but provided a correct response at T1 Comparisons of the difference between the intervention groups in percentage of women who provided an incorrect response as to whether dense breasts impact the ability of a mammogram to correctly detect cancer at T0 but provided a correct response to the question at T1
Interventions
- BEHAVIORAL Written educational brochure
- BEHAVIORAL Promotora interaction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,386 participants |
| Start Date | 2016-10-27 |
| Est. Completion | 2019-11-15 |
| Phase | NA |
What the finished NCT02910986 record still lists
NCT02910986 is an interventional study that assigns participants to a tested intervention. Its 1,386 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Written educational brochure is the first listed.
NCT02910986 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02910986 about?
NCT02910986 is a clinical study titled "Behavioral and Psychological Impact of Returning Breast Density Results to Latinas". This study will examine behavioral and psychological outcomes of breast density notification using a 3-group randomized design comparing usual written notification to two educationally enhanced approaches.
What is the current status of trial NCT02910986?
This trial is currently completed. It is a NA study. The enrollment target is 1,386 participants. The study started on 2016-10-27. Estimated completion is 2019-11-15.
What interventions are being tested in trial NCT02910986?
The interventions under investigation include: Written educational brochure (BEHAVIORAL), Promotora interaction (BEHAVIORAL).
Who is sponsoring clinical trial NCT02910986?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02910986's enrollment target sits among peer trials
1,386 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06651281 · 1,380 participants · Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- NCT05006131 · 1,395 participants
Pancreatic Cancer Screening for At-risk Individuals
- NCT02205762 · 1,400 participants · Phase 2
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
- NCT02445222 · 1,400 participants · Phase 3
CAR-T Long Term Follow Up (LTFU) Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI